Morgan Stanley analysts upgraded Johnson & Johnson (NYSE:JNJ) from Equal-Weight to Overweight on January 28, 2026.
Johnson & Johnson operates in the Healthcare sector. The stock currently trades at $227.72 with a market capitalization of $505.8B. The stock has gained 32.5% over the past 52 weeks.
